» Articles » PMID: 35618150

Sleep-wake and Arousal Dysfunctions in Post-traumatic Stress Disorder: Role of Orexin Systems

Overview
Journal Brain Res Bull
Specialty Neurology
Date 2022 May 26
PMID 35618150
Authors
Affiliations
Soon will be listed here.
Abstract

Post-traumatic stress disorder (PTSD) is a trauma-related condition that produces distressing fear memory intrusions, avoidance behaviors, hyperarousal/startle, stress responses and insomnia. This review focuses on the importance of the orexin neural system as a novel mechanism related to the pathophysiology of PTSD. Orexinergic neurons originate in the lateral hypothalamus and project widely to key neurotransmitter systems, autonomic neurons, the hypothalamic-pituitary-adrenal (HPA) axis, and fear-related neural circuits. After trauma or stress, the basolateral amygdala (BLA) transmits sensory information to the central nucleus of the amygdala (CeA) and in turn to the hypothalamus and other subcortical and brainstem regions to promote fear and threat behaviors. Orexin receptors have a prominent role in this circuit as fear conditioned orexin receptor knockout mice show decreased fear expression while dual orexin receptor antagonists (DORAs) inhibit fear acquisition and expression. Orexin activation of an infralimbic-amygdala circuit impedes fear extinction while DORA treatments enhance it. Increased orexin signaling to the amygdalo-cortical-hippocampal circuit promotes avoidance behaviors. Orexin has an important role in activating sympathetic nervous system (SNS) activity and HPA axis stress responses. Blockade of orexin receptors reduces fear-conditioned startle responses. In PTSD models, individuals demonstrate sleep disturbances such as increased sleep latency and more transitions to wakefulness. Increased orexin activity impairs sleep by promoting wakefulness and reducing total sleep time while DORA treatments enhance sleep onset and maintenance. The orexinergic neural system provides important mechanisms for understanding multiple PTSD behaviors and provides new medication targets to treat this often persistent and debilitating illness.

Citing Articles

Integrating Drug Target Information in Deep Learning Models to Predict the Risk of Adverse Events in Patients with Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder.

Miranda O, Qi X, Brannock M, Whitworth R, Kosten T, Ryan N Biomedicines. 2025; 12(12.

PMID: 39767679 PMC: 11673068. DOI: 10.3390/biomedicines12122772.


Bibliometric analysis of orexin: A promising neuropeptide.

Sun N, Wei R, Jia B, Lou T, Li Z, Nie X Medicine (Baltimore). 2024; 103(43):e40213.

PMID: 39470537 PMC: 11521092. DOI: 10.1097/MD.0000000000040213.


Brainstem transcriptomic changes in male Wistar rats after acute stress, comparing the use of duplex specific nuclease (DSN).

Lanshakov D, Sukhareva E, Bulygina V, Khozyainova A, Gerashchenko T, Denisov E Sci Rep. 2024; 14(1):21856.

PMID: 39300279 PMC: 11412992. DOI: 10.1038/s41598-024-73042-2.


Orexins in apoptosis: a dual regulatory role.

Cavalu S, Saber S, Hamad R, Abdel-Reheim M, Elmorsy E, Youssef M Front Cell Neurosci. 2024; 18:1336145.

PMID: 38699177 PMC: 11064656. DOI: 10.3389/fncel.2024.1336145.


The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress.

Jaszberenyi M, Thurzo B, Bagosi Z, Vecsei L, Tanaka M Biomedicines. 2024; 12(2).

PMID: 38398050 PMC: 10886661. DOI: 10.3390/biomedicines12020448.